Superficial intercostal plane blocks for post-sternotomy pain control rationale and design for the EPOCH CardioLink-10 randomized clinical trial.

In 30 seconds

The EPOCH CardioLink-10 trial is a double-blind, placebo-controlled, multicenter randomized trial assessing the impact of continuous bilateral superficial parasternal intercostal plane (SPIP) blocks on opioid consumption and recovery in patients post-cardiac surgery via median sternotomy. The primary outcome is cumulative postoperative opioid use measured in morphine milligram equivalents up to 72 hours post-catheter insertion.

Key findings

• The trial aims to evaluate opioid consumption up to 72 hours post-catheter insertion.
• Secondary endpoints include median pain scores and incidence of delirium over 72 hours.
• The study involves participants from four Canadian sites.

Why it matters

Effective pain management post-cardiac surgery is crucial for recovery and can reduce opioid consumption, which is important for minimizing potential complications and improving patient outcomes.